ğŸ§¬ GENE OF THE WEEK: TPMT

A life-saving pharmacogenomic test. TPMT variants can cause fatal bone marrow suppression from standard doses of thiopurine drugs.

TPMT Activity Levels:

Normal (89% of population):
âœ… Full enzyme activity
âœ… Standard dosing OK
âœ… Normal drug metabolism

Intermediate (10%):
âš ï¸ 50% dose reduction needed
âš ï¸ Increased toxicity risk
âš ï¸ Requires closer monitoring

Poor Metabolizer (0.3%):
ğŸš« 90% dose reduction or avoid
ğŸš« Severe myelosuppression risk
ğŸš« Consider alternative therapy

Affected Drugs:

ğŸ’Š Azathioprine (Imuran)
ğŸ’Š Mercaptopurine (6-MP)
ğŸ’Š Thioguanine

Clinical Uses:
â†’ Inflammatory bowel disease
â†’ Leukemia
â†’ Organ transplant
â†’ Autoimmune diseases

FDA recommends TPMT testing before prescribing thiopurines. Testing can prevent life-threatening bone marrow toxicity.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #TPMT #Pharmacogenomics #DrugSafety #Bioscope
